Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,297 papers from all fields of science
Search
Sign In
Create Free Account
Recombinant EphB4-HSA Fusion Protein
Known as:
sEphB4-HSA
A recombinant fusion protein composed of the full-length extracellular domain (soluble) of human receptor tyrosine kinase ephrin type-B receptor 4…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
NCIt Antineoplastic Agent Terminology
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
A phase Ib study of sEphB4-HSA combined with first-line chemotherapy in patients (pts) with advanced pancreatic (PC) and biliary cancers (BC).
D. Hanna
,
S. Iqbal
,
+11 authors
A. El-Khoueiry
2020
Corpus ID: 219779700
4640Background: EphB4, a receptor kinase expressed in most epithelial tumors, binds EphrinB2 to affect cancer cell growth…
Expand
2020
2020
A phase II study of sEphB4-HSA in metastatic castration-resistant prostate cancer (mCRPC).
Michael C. Burns
,
V. Sagar
,
+6 authors
M. Hussain
2020
Corpus ID: 213626861
TPS274Background: The EphB4/EphrinB2 pathway is a promising therapeutic target for patients with mCRPC. EphB4 expression is…
Expand
2018
2018
A first-in-human phase I study of sEphB4-HSA (sEphB4) with expansion in hepatocellular (HCC) and cholangiocarcinoma (CCA).
Jacob S. Thomas
,
H. Lenz
,
+11 authors
A. El-Khoueiry
2018
Corpus ID: 196491437
285Background: EphrinB4, a receptor kinase, is associated with stage and survival in epithelial cancers. sEphB4 is a fusion…
Expand
2016
2016
Circulating tumor cell analysis in a first-in-human phase I study of sEphB4-HSA, an inhibitor of EphrinB2-EphB4 signaling
Cory M. Hugen
,
Gareth Morrison
,
+11 authors
A. Goldkorn
2016
Corpus ID: 79370358
2014
2014
Abstract 1758: Targeting EphB4 with a novel antibody in acute leukemia
Miriam Y Kim
,
Aparna Jorapur
,
+5 authors
Akil A. Merchant
2014
Corpus ID: 70779112
Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA Introduction: EphB4, a receptor tyrosine kinase, binds to…
Expand
2014
2014
In vivo efficacy of sEphB4-HSA combined with Bevacizumab.
Li Xiuqing
,
W. C. Wesley
,
+10 authors
Liu Ren
2014
Corpus ID: 77052952
2014
2014
Abstract 2601: EphB4/EphrinB2 targeting increases the efficacy of cisplatin in triple negative breast cancer
G. Yang-Kolodji
,
Ren Liu
,
A. Mehta
,
P. Gill
,
D. Tripathy
2014
Corpus ID: 70397737
Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA Triple negative breast cancer (TNBC) represents a…
Expand
2013
2013
Abstract 4356: EphB4 as a novel therapeutic target for head-neck SCC.
Ren Liu
,
Hai-Yun Yen
,
+5 authors
P. Gill
2013
Corpus ID: 71652934
Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC Introduction: Receptor tyrosine kinase EphB4 and its…
Expand
2012
2012
Biophysical characterization and stabilization of the recombinant albumin fusion protein sEphB4-HSA.
Shuai Shi
,
Jing Liu
,
+4 authors
D. Volkin
Journal of Pharmacy and Science
2012
Corpus ID: 2162608
The use of albumin fusion proteins as therapeutic drug candidates is an attractive approach to design novel biopharmaceuticals…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE